Skip to content

Clinical trials

Withdrawn Phase 4 Pulmonary Disease, Chronic Obstructive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 4 Status: Withdrawn Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20081
20091
20101
20113
20122
20141
20163
20171
20181
20192
20212
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AstraZeneca2
GlaxoSmithKline2
Chiesi Farmaceutici S.p.A.1
Dayton VA Medical Center1
Hull University Teaching Hospitals NHS Trust1
Hôpital de Verdun1
Imperial College London1
Jorgen Vestbo1
NHS Greater Glasgow and Clyde1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive24
alpha 1-Antitrypsin Deficiency2
Asthma1
Bronchitis, Chronic1
Cough1
Emergencies1
Emphysema1
Heart Failure1
Hypertension, Pulmonary1
Infections1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.